Virginia Retirement Systems Et Al Rocket Pharmaceuticals, Inc. Transaction History
Virginia Retirement Systems Et Al
- $14.2 Billion
- Q2 2025
A detailed history of Virginia Retirement Systems Et Al transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Virginia Retirement Systems Et Al holds 17,400 shares of RCKT stock, worth $54,810. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,400
Previous 17,400
-0.0%
Holding current value
$54,810
Previous $116,000
63.79%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding RCKT
# of Institutions
221Shares Held
98.4MCall Options Held
611KPut Options Held
474K-
Rtw Investments, LP New York, NY17.7MShares$55.7 Million0.67% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx8.36MShares$26.3 Million0.35% of portfolio
-
Black Rock Inc. New York, NY6.19MShares$19.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.12MShares$19.3 Million0.0% of portfolio
-
Westfield Capital Management CO LP Boston, MA4.82MShares$15.2 Million0.17% of portfolio
About ROCKET PHARMACEUTICALS, INC.
- Ticker RCKT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 75,683,696
- Market Cap $238M
- Description
- Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...